NCT03650140

Pharmacokinetics and Pharmacodynamics of Anthocyanins

PKPD of Anthocyanins After Oral Cherry Juice Concentrate in Gout Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Rutgers, The State University of New Jersey · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.

Conditions

• Gout

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Tart cherry extract 60 mL	Subjects will receive a single 60 mL oral dose of tart cherry extract.
DIETARY_SUPPLEMENT	Tart cherry extract 120 mL	Subjects will receive a single 120 mL oral dose of tart cherry extract.

Timeline

• Start date: 2019-02-01
• Primary completion: 2022-06-01
• Completion: 2022-06-06
• First posted: 2018-08-28
• Last updated: 2023-01-09

Locations

1 site across 1 country: United States